anti-Viral COVID 19 Nucleocapsid (NP) Humanized Coronavirus Monoclonal Antibody | anti-COVID-19 antibody
Anti-SARS-CoV-2 Nucleocapsid / COVID-19, Humanized antibody
Reactivity
Viral
Applications
ELISA, Functional Assay, Lateral Flow
Purity
Purity: >95% by HPLC & SDS-PAGEPurification: Protein A purified
Synonyms
COVID 19 Nucleocapsid (NP) Humanized Coronavirus; Monoclonal Antibody; Anti-SARS-CoV-2 Nucleocapsid / COVID-19; Humanized antibody; 2019 Novel Coronavirus; Coronavirus; CoV; COVID-19 virus; HCoV-2; Human Coronavirus 2019; SARS2; SARS-CoV-2; Severe acute respiratory syndrome coronavirus 2; Nucleocapsid; Nucleoprotein (NP); anti-COVID-19 antibody
Host
Cultured in vitro
Reactivity
Viral
Clonality
Monoclonal
Isotype
Human IgG1
Clone Number
2D8
Purity/Purification
Purity: >95% by HPLC & SDS-PAGE
Purification: Protein A purified
Purification: Protein A purified
Form/Format
Liquid; Supplied in 0.01 M PBS without preservative.
Applicable Applications for anti-COVID-19 antibody
ELISA (EIA), Lateral Flow (rapid test) (LFA)
Application Notes
Other applications have not been tested.
The optimal dilutions should be determined by end user.
The optimal dilutions should be determined by end user.
Immunogen
Recombinant SARS-CoV-2 N protein (Expression system with E.Coli).
Dry Ice Shipment
Extra charge fee may add to your shipping cost as dry ice is required to ship this product.
Preparation and Storage
Ships on Dry Ice.
Aliquot and store at -20°C for long term.
Avoid repeated freeze and thaw cycles.
Aliquot and store at -20°C for long term.
Avoid repeated freeze and thaw cycles.
Related Product Information for anti-COVID-19 antibody
The 2019 novel coronavirus, abbreviated as 2019-ncov, is a new strain of coronavirus discovered in the human body in 2019. The symptoms of the virus are fever, fatigue, dry cough, and progressive dyspnea. In severe cases, the symptoms are acute respiratory distress syndrome, septic shock, metabolic acidosis and coagulation dysfunction that can’t be corrected. The virus has been confirmed to exist the phenomenon of human-to-human transmission, the shortest incubation period of the virus is only 1 day, and the longest incubation period is 14 days. The patients in incubation period is contagious and there is no specific treatment for the disease. . After a human is infected with a new virus for the first time, the body's immune system will immune-defend the virus and produce specific antibodies. Generally, IgM antibody will appear in 1-2 weeks and IgG antibody will appear in 4 weeks.
Product Categories/Family for anti-COVID-19 antibody
References
1. World Health Organization: Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim Guidance.
2. "Pneumonia diagnosis and treatment program for novel coronavirus infection" of the National Health Commission of People’s Republic of China (Trial Version 3).
3). World Health Organization: Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim Guidance.
2. "Pneumonia diagnosis and treatment program for novel coronavirus infection" of the National Health Commission of People’s Republic of China (Trial Version 3).
3). World Health Organization: Clinical management of severe acute respiratory infection when Novel coronavirus (nCoV) infection is suspected: Interim Guidance.
Similar Products
Product Notes
The COVID-19 (Catalog #AAA355888) is an Antibody produced from Cultured in vitro and is intended for research purposes only. The product is available for immediate purchase. The Anti-SARS-CoV-2 Nucleocapsid / COVID-19, Humanized antibody reacts with Viral and may cross-react with other species as described in the data sheet. AAA Biotech's COVID 19 Nucleocapsid (NP) Humanized Coronavirus can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Lateral Flow (rapid test) (LFA). Other applications have not been tested. The optimal dilutions should be determined by end user. Researchers should empirically determine the suitability of the COVID-19 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process. It is sometimes possible for the material contained within the vial of "COVID 19 Nucleocapsid (NP) Humanized Coronavirus, Monoclonal Antibody" to become dispersed throughout the inside of the vial, particularly around the seal of said vial, during shipment and storage. We always suggest centrifuging these vials to consolidate all of the liquid away from the lid and to the bottom of the vial prior to opening. Please be advised that certain products may require dry ice for shipping and that, if this is the case, an additional dry ice fee may also be required.Precautions
All products in the AAA Biotech catalog are strictly for research-use only, and are absolutely not suitable for use in any sort of medical, therapeutic, prophylactic, in-vivo, or diagnostic capacity. By purchasing a product from AAA Biotech, you are explicitly certifying that said products will be properly tested and used in line with industry standard. AAA Biotech and its authorized distribution partners reserve the right to refuse to fulfill any order if we have any indication that a purchaser may be intending to use a product outside of our accepted criteria.Disclaimer
Though we do strive to guarantee the information represented in this datasheet, AAA Biotech cannot be held responsible for any oversights or imprecisions. AAA Biotech reserves the right to adjust any aspect of this datasheet at any time and without notice. It is the responsibility of the customer to inform AAA Biotech of any product performance issues observed or experienced within 30 days of receipt of said product. To see additional details on this or any of our other policies, please see our Terms & Conditions page.Item has been added to Shopping Cart
If you are ready to order, navigate to Shopping Cart and get ready to checkout.
